E. Gautier‐Veyret
发表
F. Stanke-Labesque,
R. Guilhaumou,
E. Gautier‐Veyret,
2020,
Pharmacology & Therapeutics.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2015,
Therapeutic drug monitoring.
S. Bailly,
J. Timsit,
L. Bouadma,
2020,
Antimicrobial Agents and Chemotherapy.
F. Stanke-Labesque,
J. Quesada,
E. Gautier‐Veyret,
2015,
Antimicrobial Agents and Chemotherapy.
J. Pépin,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2017,
Pharmacology & therapeutics.
F. Stanke-Labesque,
J. Alffenaar,
F. Lamoureux,
2021,
Journal of clinical medicine.
F. Stanke-Labesque,
C. Chapuis,
E. Gautier‐Veyret,
2018,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
L. Rostaing,
F. Stanke-Labesque,
Johan Noble,
2021,
Journal of clinical medicine.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2020,
British journal of clinical pharmacology.
E. Gautier‐Veyret,
A. Toffart,
B. Revol,
2020,
British journal of clinical pharmacology.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2018,
Fundamental & clinical pharmacology.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2018,
bioRxiv.
D. Concordet,
B. Mourvillier,
C. Schwebel,
2021,
Clinical pharmacology and therapeutics.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2012,
European Respiratory Journal.
F. Stanke-Labesque,
E. Gautier‐Veyret,
A. Thiébaut-Bertrand,
2022,
Journal of clinical medicine.
S. Bailly,
F. Stanke-Labesque,
P. Gandia,
2020,
Fundamental & clinical pharmacology.
F. Stanke-Labesque,
P. Bedouch,
E. Gautier‐Veyret,
2020,
British journal of clinical pharmacology.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2019,
Antimicrobial Agents and Chemotherapy.
P. Bedouch,
E. Gautier‐Veyret,
M. Cornet,
2018,
British journal of clinical pharmacology.
F. Stanke-Labesque,
E. Gautier‐Veyret,
J. Jourdil,
2018,
Therapeutic drug monitoring.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2015,
Prostaglandins & other lipid mediators.
Edouard F. Bonneville,
F. Stanke-Labesque,
M. Baudrant,
2020,
British journal of clinical pharmacology.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2021,
Pharmaceutics.
B. Bonaz,
S. Bailly,
F. Stanke-Labesque,
2019,
British journal of clinical pharmacology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2018,
Pharmacological research.
B. Bonaz,
F. Stanke-Labesque,
F. Lemaitre,
2017,
Analytical and Bioanalytical Chemistry.
F. Stanke-Labesque,
E. Gautier‐Veyret,
T. Debillon,
2022,
Antimicrobial agents and chemotherapy.
F. Stanke-Labesque,
E. Gautier‐Veyret,
P. Malvezzi,
2020,
Clinical biochemistry.
V. Haufroid,
S. Broutin,
J. Guitton,
2022,
British journal of clinical pharmacology.
V. Haufroid,
N. Pallet,
B. Royer,
2021,
Annals of oncology : official journal of the European Society for Medical Oncology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2014,
Cardiovascular research.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2014
.
Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis
J. Gottenberg,
F. Stanke-Labesque,
A. Baillet,
2021,
Fundamental & clinical pharmacology.
B. Bonaz,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2019,
Analytica chimica acta.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2017,
Pharmacogenomics.
F. Stanke-Labesque,
L. Payen,
M. Chenel,
2021,
Pharmaceutical Research.
F. Stanke-Labesque,
E. Gautier‐Veyret,
X. Fonrose,
2017,
Clinical pharmacology and therapeutics.
F. Lemaitre,
E. Gautier‐Veyret,
B. Hennart,
2019,
Medecine et maladies infectieuses.
F. Stanke-Labesque,
E. Gautier‐Veyret,
F. Thomas,
2023,
British Journal of Clinical Pharmacology.
F. Stanke-Labesque,
J. Quesada,
E. Gautier‐Veyret,
2015,
Antimicrobial Agents and Chemotherapy.